During the past decade, Associated Internal Medicine Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Associated Internal Medicine Specialists" are "Type 2 Diabetes" (2 trials), "Hospitalized Elderly" (1 trials), "Influenza A" (1 trials), "Influenza B" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Associated Internal Medicine Specialists" in a lesser frequency.

Most popular intervention types in "Associated Internal Medicine Specialists" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin" (2 trials), "Placebo matching with Dapagliflozin" (2 trials), "Saxagliptin" (2 trials), "Abatacept" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Associated Internal Medicine Specialists" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Associated Internal Medicine Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Associated Internal Medicine Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Associated Internal Medicine Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".